Doxorubicin resistance in human melanoma cells: MDR-1 and glutathione S-transferase π gene expression

Cheppail Ramachandran, Kang Yuan Zhao Kang Yuan, Ling Huang Xiao Ling Huang, Awtar Krishan

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

Cellular drug resistance is believed to involve P-glycoprotein-related drug efflux as well as xenobiotic detoxification. In the present study, we analyzed five human melanoma cell lines with 1- to 6-fold doxorubicin resistance for doxorubicin retention and MDR-1 and GST π gene expression. All the cell lines had high doxorubicin retention, and efflux blockers such as trifluoperazine and verapamil did not have a major effect on drug retention or cytotoxicity. Even though all the cell lines carried the MDR-1 and GST π genes, gene amplification was not associated with drug resistance. Both laser flow cytometry and immunoperoxidase staining showed high expression of C-219 reactive P-glycoprotein in some of the resistant cells which was not accompanied by either high drug efflux or sensitivity to doxorubicin efflux blockers.

Original languageEnglish (US)
Pages (from-to)743-751
Number of pages9
JournalBiochemical Pharmacology
Volume45
Issue number3
DOIs
StatePublished - Feb 9 1993

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Fingerprint Dive into the research topics of 'Doxorubicin resistance in human melanoma cells: MDR-1 and glutathione S-transferase π gene expression'. Together they form a unique fingerprint.

  • Cite this